~~<i id='37E3A134A5'><strike id='37E3A134A5'><tt id='37E3A134A5'><pre id='37E3A134A5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：leisure time 2025-09-28 18:57:24 - browse：245

A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

See below for an archived chat with Helen Branswell about these issues and more.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： STAT Summit: Ending the crisis of Black deaths in the U.S.

focus

leisure time

hotspot

focus

Wikipedia

hotspot

AdobeAlmostassoonasChatGPTwasreleasedtothepublic,doctorsbeganfocusingonhowtheycouldharnessartificial

WSS

STAT Summit: The economic case for universal basic health care

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Is there really a nursing shortage in the U.S.?

Roche acquires Telavant from Roivant, adding experimental IBD treatment

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

STAT Summit: The economic case for universal basic health care

leisure time

entertainment

focus

Virginia high school admissions case could be legal follow

Roche drug slashes death risk in early

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Readout Newsletter: Biotech news today

Anesthesiologist group: stop taking Ozempic before surgery

ADCs take center stage as promising cancer treatments

Psychedelics group wrestles with new pharma identity

STAT Summit: Ending the crisis of Black deaths in the U.S.

Duchenne breakthrough therapy leaves behind pioneering families

Is there really a nursing shortage in the U.S.?

leisure time

J&J lung cancer data amount to new salvo against AstraZeneca

STAT Summit: The economic case for universal basic health care

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Roivant's CEO is a star, but biotech's black hole persists

Health tech investors get more selective as pandemic boom fades

hotspot

focus

Wikipedia

hotspot